FY2024 Earnings Estimate for CMPX Issued By Leerink Partnrs
Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) – Equities researchers at Leerink Partnrs raised their FY2024 earnings per share estimates for shares of Compass Therapeutics in a research note issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens now forecasts that the company will post earnings of ($0.39) per share for the year, up […]
![FY2024 Earnings Estimate for CMPX Issued By Leerink Partnrs](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/compass-therapeutics-inc-logo-1200x675.jpg?v=20211118075932&w=240&h=240&zc=2)